PeptideStack
5.2kquestions
20kanswers
220users

Does holding at 12.5 mg for eight weeks before escalating reduce headache?

Asked 11 Mar 2025Modified 17 months agoViewed 11k times
12

Stated plainly: 12.5 mg · eight weeks · headache.

The empirical answer seems settled. The explanation does not.

If the honest answer is that nobody knows, I would rather hear that than a plausible story.

Is the standard explanation correct, and if so, what is the evidence for it?

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questionsdose-escalation
dose-escalation

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled…

103 questions
shareeditfollowflag
TR
askedtobias_reint20k3811 Mar 2025
2Is this about the licensed schedule or about going slower than it? – nine_point_nine 10 months ago
How long was the gap? Under a week and over a month are different answers. – linnea_wahlberg 8 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 11k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.